Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (111-120 of 181) with videos related to

Pageof 19
Sort By:
Nuklearmedizin. Nuclear Medicine|January 27, 2023
[Is there an unmet need to establish a young talent section "Young DGN" within the German Society of Nuclear Medicine (DGN)? - Results of a 2021/2022 web-based survey among German Nuclear Medicine professionals]Yasemin Aylin Sahin, Friederike Eilsberger, Eric Einspänner, et al.
JAMA Surgery|July 19, 2013
Cystic lesions with suspected soft tissue infiltrationTheresia Weber, Alexandra von Baer, Markus Schultheiß, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2014
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinomaElena-Daphne Thies, Karina Tanase, Uwe Maeder, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2012
Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patientsFrederik A Verburg, Uwe Mäder, Karina Tanase, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in GermanySmita George Thoduka, Luka Flegar, Christer Groeben, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
"Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide" on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake newsLuca Giovanella, Frederik A Verburg, Petra Petranović Ovčariček, et al.
International Journal of Molecular Sciences|September 13, 2025
Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists-A Systematic Review and Meta-AnalysisQi Wang, Damiano Librizzi, Shamim Bagheri, et al.
Nuklearmedizin. Nuclear Medicine|April 30, 2019
[Procedural guideline for Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (version 5)]Frederik A Verburg, Matthias Schmidt, Michael C Kreissl, et al.
Endocrine-Related Cancer|June 30, 2016
Myeloid neoplasms after chemotherapy and PRRT: myth and realityLisa Bodei, Irvin M Modlin, Markus Luster, et al.
European Journal of Radiology|October 12, 2010
Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancerSandra Pauls, Stefan A Schmidt, Markus S Juchems, et al.
Pageof 19

Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Nuklearmedizin. Nuclear Medicine|January 27, 2023
[Is there an unmet need to establish a young talent section "Young DGN" within the German Society of Nuclear Medicine (DGN)? - Results of a 2021/2022 web-based survey among German Nuclear Medicine professionals]Yasemin Aylin Sahin, Friederike Eilsberger, Eric Einspänner, et al.
JAMA Surgery|July 19, 2013
Cystic lesions with suspected soft tissue infiltrationTheresia Weber, Alexandra von Baer, Markus Schultheiß, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2014
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinomaElena-Daphne Thies, Karina Tanase, Uwe Maeder, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2012
Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patientsFrederik A Verburg, Uwe Mäder, Karina Tanase, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in GermanySmita George Thoduka, Luka Flegar, Christer Groeben, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2020
"Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide" on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake newsLuca Giovanella, Frederik A Verburg, Petra Petranović Ovčariček, et al.
International Journal of Molecular Sciences|September 13, 2025
Theranostic Radiopharmaceuticals of Somatostatin Receptors for Patients with Neuroendocrine Tumors: Agonists Versus Antagonists-A Systematic Review and Meta-AnalysisQi Wang, Damiano Librizzi, Shamim Bagheri, et al.
Nuklearmedizin. Nuclear Medicine|April 30, 2019
[Procedural guideline for Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (version 5)]Frederik A Verburg, Matthias Schmidt, Michael C Kreissl, et al.
Endocrine-Related Cancer|June 30, 2016
Myeloid neoplasms after chemotherapy and PRRT: myth and realityLisa Bodei, Irvin M Modlin, Markus Luster, et al.
European Journal of Radiology|October 12, 2010
Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancerSandra Pauls, Stefan A Schmidt, Markus S Juchems, et al.
Pageof 19